| RS2149172338 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149172715 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2149172789 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149174007 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149175323 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2149175646 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149175874 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149175937 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149176119 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2149176927 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2149177611 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2149181831 |
NFKB1
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2149181883 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149181968 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149182005 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149184604 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149184630 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149185686 |
MUTYH
|
Health Risk |
Likely pathogenic |
— |
| RS2149186919 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149190155 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149192562 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149192634 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2149192665 |
NFKB1
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2149192697 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149199098 |
STIL
|
Health Risk |
Likely pathogenic |
Microcephaly 7, primary |
| RS2149201245 |
WDFY3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2149203291 |
NFKB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency, common variable |
| RS2149203324 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149203505 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149203552 |
NFKB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS2149205109 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149206488 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149208637 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149220092 |
POMC
|
Health Risk |
Likely pathogenic |
Obesity, Obesity |
| RS2149220731 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149221544 |
CAMTA1
|
Health Risk |
Likely pathogenic |
— |
| RS2149221667 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2149221946 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149222635 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2149227839 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149230078 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2149230139 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2149231471 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149231722 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149234796 |
PROM1
|
Health Risk |
Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS2149244412 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149244602 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2149244826 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149244988 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149245072 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149245252 |
DMD
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS2149245287 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149245623 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149248633 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2149249120 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2149252891 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149253335 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149253473 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149254230 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149256470 |
LHX4
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2149256621 |
DEPDC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149256695 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149256957 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2149257286 |
DMD
|
Health Risk |
Pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2149257310 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149257421 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149258165 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2149259725 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149260122 |
DOCK7
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149260739 |
TOE1
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 7, Pontocerebellar hypoplasia type 7 |
| RS2149262033 |
LARP7
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic primordial dwarfism, Alazami type |
| RS2149263256 |
LHX4
|
Health Risk |
Pathogenic |
— |
| RS2149263749 |
LARP7
|
Health Risk |
Likely pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS2149263988 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS2149264030 |
FRYL
|
Health Risk |
Likely pathogenic |
FRYL-related disorder, FRYL-related disorder |
| RS2149264374 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2149264484 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2149265022 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2149265203 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2149265753 |
LARP7
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS2149265835 |
LARP7
|
Health Risk |
Pathogenic |
— |
| RS2149266119 |
LARP7
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS2149266244 |
LARP7
|
Health Risk |
Pathogenic |
— |
| RS2149266450 |
LARP7
|
Health Risk |
Pathogenic |
— |
| RS2149266454 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149266489 |
LARP7
|
Health Risk |
Likely pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS2149267082 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149267113 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2149267795 |
LARP7
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS2149267842 |
LARP7
|
Health Risk |
Pathogenic |
— |
| RS2149268621 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS2149273784 |
DNMT3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2149277178 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2149278721 |
LARP7
|
Health Risk |
Pathogenic |
— |
| RS2149286477 |
LARP7
|
Health Risk |
Pathogenic |
— |
| RS2149288272 |
MYO6
|
Health Risk |
Likely pathogenic |
Ear malformation, Ear malformation |
| RS2149288538 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS2149289125 |
DNMT3A
|
Health Risk |
Pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS2149298999 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2149300394 |
DNMT3A
|
Health Risk |
Pathogenic |
— |